Overviews and analysis of the U.S. FDA′s new approvals in the first half year of 2016 / 国际药学研究杂志
Journal of International Pharmaceutical Research
;
(6): 774-784, 2016.
Article
in Chinese
| WPRIM
| ID: wpr-498164
ABSTRACT
In the first half year of 2016,the U.S. food and drug administration(FDA)approved 9 new molecular entities and 8 new biologic license applications. According to the prescription information for professionals,this article introduces the description, mechanism of action and clinical studies;briefly describes the box warning,indications and usage,dosage and administration,dos?age form and strength,contraindications,warning and precautions,adverse reactions,drug interaction and use in special population of these new drugs. In addition,the first and critical events in the history of new drug development and reaserch are emphasized.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of International Pharmaceutical Research
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS